Back to Search
Start Over
Barriers to Access to New Gonorrhea Point-of-Care Diagnostic Tests in Low- and Middle-Income Countries and Potential Solutions: A Qualitative Interview-Based Study
- Source :
- Sexually Transmitted Diseases
- Publication Year :
- 2020
- Publisher :
- Lippincott Williams & Wilkins, 2020.
-
Abstract
- This study showed strong public interest for 2 hypothetical diagnostic tests for Neisseria gonorrhoeae/Chlamydia trachomatis detection and N. gonorrhoeae resistance marker identification, but highlighted some challenges relating to their adoption. Supplemental digital content is available in the text.<br />Background To assess the potential market for 2 hypothetical diagnostic tests, one for Neisseria gonorrhoeae/Chlamydia trachomatis (NG/CT) detection and one for NG antimicrobial resistance (AMR) marker identification. Methods This is a qualitative interview-based study. Semistructured interviews with global- and country-level experts were performed. Interviewees were provided with simplified versions of Foundation for Innovative New Diagnostics/World Health Organization–developed target product profiles for each test. Interviewees were asked to comment on use cases, test characteristics, and factors that may influence test adoption. Results Twenty-one experts were interviewed, including 15 country-level experts (from South Africa, India, Zimbabwe, Ghana, China, Peru, Kenya, and Cambodia). Interviewees welcomed an NG/CT point-of-care test, with near-universal preference for a test that could detect symptomatic and asymptomatic infections. Interviewees also saw value in a test that could be used to screen high-risk populations. Factors that may drive adoption of the NG/CT test identified by interviewees included price, cost-effectiveness, evidence of public health benefit, and World Health Organization guidance. Interviewees felt that AMR test use would likely be limited to patients failing first-line treatment. Conclusions Although the potential target population for an NG/CT diagnostic test in low- and middle-income countries is sizeable, there are areas of uncertainty relating to the price of the test and its intended use, warranting further research to determine the most effective positioning. An NG AMR test would likely be used very selectively.
- Subjects :
- Microbiology (medical)
medicine.medical_specialty
Gonorrhea
Chlamydia trachomatis
Dermatology
urologic and male genital diseases
Original Studies
03 medical and health sciences
0302 clinical medicine
medicine
Humans
030212 general & internal medicine
Product (category theory)
Developing Countries
Point of care
030505 public health
business.industry
Public health
Qualitative interviews
Public Health, Environmental and Occupational Health
Diagnostic test
Chlamydia Infections
medicine.disease
Neisseria gonorrhoeae
female genital diseases and pregnancy complications
Test (assessment)
Infectious Diseases
Low and middle income countries
Point-of-Care Testing
Family medicine
0305 other medical science
business
Subjects
Details
- Language :
- English
- ISSN :
- 15374521 and 01485717
- Volume :
- 47
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Sexually Transmitted Diseases
- Accession number :
- edsair.doi.dedup.....bcd080985226b7a5bbfe8c28caa00a6a